CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) (“CNS” or the “Company”), announced that its partner, WPD Pharmaceuticals (“WPD”), a Polish corporation founded by Dr. Waldemar Priebe, the founder of the Company, was awarded a $5,798,875 grant from the EU/Polish National Center for Research and Development
December 11, 2019
· 4 min read